Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.15M | 1.16M | 1.09M | 1.01M | 1.32M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.87M | 1.88M | 1.92M | 1.78M | 2.80M |
| Operating Income | -1.87M | -1.88M | -1.92M | -1.78M | -2.80M |
| Income Before Tax | -1.57M | -1.58M | -2.17M | -2.01M | -2.60M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.57M | -1.58M | -2.17M | -2.01M | -2.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.57M | -1.58M | -2.17M | -2.01M | -2.60M |
| EBIT | -1.87M | -1.88M | -1.92M | -1.78M | -2.80M |
| EBITDA | -1.87M | -1.87M | -1.91M | -1.77M | -2.78M |
| EPS Basic | -0.08 | -0.08 | -0.12 | -0.11 | -0.14 |
| Normalized Basic EPS | -0.05 | -0.05 | -0.07 | -0.07 | -0.09 |
| EPS Diluted | -0.08 | -0.08 | -0.12 | -0.11 | -0.14 |
| Normalized Diluted EPS | -0.05 | -0.05 | -0.07 | -0.07 | -0.09 |
| Average Basic Shares Outstanding | 20.65M | 20.65M | 18.77M | 18.77M | 18.29M |
| Average Diluted Shares Outstanding | 20.65M | 20.65M | 18.77M | 18.77M | 18.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |